openPR Logo
Press release

Human Microbiome Market Report by Size, Status and Forecast 2022-2030

09-19-2022 07:03 AM CET | Health & Medicine

Press release from: Persistence Market Research

Trillions of microorganisms live in and on the human body. This collection of microorganisms is called human microbiome. These microorganisms include fungi, bacteria and archaea. Recent advances in DNA sequencing technologies has allowed for more comprehensive examination of these microorganisms and evolved intimate relationships with their hosts. Scientists and researchers recognized that the microbiome is responsible for metabolic and developmental processes, such as food digestion, vitamin synthesis and brain function, of the human body.

The global human microbiome market is categorized based on various diseases, applications and by products. The disease segment is further sub-segmented into obesity, diabetes, auto-immune diseases, central nervous system disorders, cancer and diarrhea. Obesity and diarrhea are the largest sub-segments in the global human microbiome market.

This is due to increasing lifestyle diseases and aging population. The application segment includes diagnostic and therapeutic applications of the human microbiome. Therapeutic application is the leading sub-segment in the global human microbiome market. This is due rising population and increasing prevalence of diseases.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3477

The product segment is further sub-segmented into prebiotic and probiotic, medical food and supplements. Prebiotic and probiotic is the largest sub-segment in this market due to increased potential of these products in the treatment of lifestyle diseases.

In terms of geographic, North America and Europe dominates the global human microbiome market due to improved biotechnological and microbiological research infrastructure. In addition, rising incidences of life style diseases and autoimmune disorders has also fueled the growth of human microbiome market in these regions.

The U.S. represents the largest market for human microbiome followed by Canada in North America. France, Germany, Spain and the U.K. holds major share of human microbiome market in Europe. However, Asia is expected to show high growth rates in the next five years in global human microbiome market.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/3477

This is due to improving research infrastructure in the region. In additions, several government associations are also supporting in the growth of human microbiome market in the region by providing funds and grants to increase research in the field of life science. China and India are expected to be the fastest growing human microbiome markets in Asia.

In recent time, increasing prevalence of diseases, such as diabetes, cancer and obesity, and rising number of geriatric populations are some of the major drivers of the global human microbiome market. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), diabetes affected 285 million people worldwide in 2010 and the number is expected to reach 439 million by 2030. This increasing prevalence of diabetes has resulted in significant rise in demand of human microbiome based therapies for treatment of the disease.

In addition, increasing awareness among people about advantages of microbiome products is also supporting in growth of the global human microbiome market. However, stringent government regulations obstruct the growth of global human microbiome market. Advancement in biomedical science develops opportunity for the global human microbiome market. Increasing mergers and acquisitions between major players and government associations is key trend of the global human microbiome market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/3477

Some of the major companies operating in the global human microbiome market are Enterome Bioscience, Merck, Yakult, DuPont, ViThera Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome Inc., Vedanta BioSciences, Osel and Metabiomics Corporation.

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Microbiome Market Report by Size, Status and Forecast 2022-2030 here

News-ID: 2738879 • Views:

More Releases from Persistence Market Research

Reprocessed Single-Use Devices Market to Grow at 13.8% CAGR Through 2032, Persistence Market Research Reports
Reprocessed Single-Use Devices Market to Grow at 13.8% CAGR Through 2032, Persis …
Introduction In the evolving landscape of healthcare, cost pressures, sustainability concerns, and regulatory changes are driving novel strategies. One of the standout trends is the reprocessing of single-use medical devices (SUDs). Instead of discarding devices after one use, certain classes of single-use devices can be cleaned, sterilized, validated, and reused under stringent controls. This practice offers potential savings, waste reduction, and resource efficiency-if done safely and in compliance with regulations. Download Sample
Global Bicycle Tire Market Set to Surge from USD 9,671.5 Million in 2025 to USD 16,361.6 Million by 2032 at 7.8% CAGR
Global Bicycle Tire Market Set to Surge from USD 9,671.5 Million in 2025 to USD …
The Bicycle Tire Market is experiencing substantial growth globally, driven by the increasing adoption of bicycles as eco-friendly and cost-effective transportation alternatives. According to Persistence Market Research, the global market is estimated to reach US$ 9,671.5 Mn by 2025, with further growth projected to reach US$ 16,361.6 Mn by 2032, registering a CAGR of 7.8% from 2025 to 2032. Rising fuel prices and heightened environmental awareness have accelerated the shift
EVTOL Aircraft Market Growth Driven by Electrification, Infrastructure Development, and Auto-to-EVTOL Transition, Projected to Reach USD 2,931.0 Million by 2032 at 23.3% CAGR
EVTOL Aircraft Market Growth Driven by Electrification, Infrastructure Developme …
The eVTOL aircraft market is emerging as a transformative segment in the aerospace and urban air mobility sector. According to Persistence Market Research, the global eVTOL aircraft market is expected to generate US$ 676.5 million in revenue by 2025, and grow at an impressive CAGR of 23.3% to reach US$ 2,931.0 million by 2032. This exponential growth is fueled by technological advancements, rising urbanization, and increasing investments in sustainable air
Global Car Rental Market Set to Surge from USD 140.4 Billion in 2025 to USD 277.2 Billion by 2032, Growing at 11.2% CAGR
Global Car Rental Market Set to Surge from USD 140.4 Billion in 2025 to USD 277. …
The global car rental market is witnessing a remarkable expansion, fueled by rising consumer demand, growing tourism, and the increasing need for convenient mobility solutions. According to Persistence Market Research, the market size is projected to grow from US$ 140.4 billion in 2025 to US$ 277.2 billion by 2032, reflecting a CAGR of 11.2% over the forecast period from 2025 to 2032. This robust growth can be attributed to factors

All 5 Releases


More Releases for Therapeutic

Exosome Therapeutic Market : Detailed Overview
Introduction: The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028. Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market. Browse 147 Market Data Tables and 115
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The